# Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma

> **NCT03488550** · PHASE1 · COMPLETED · sponsor: **Annexon, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Open-angle Glaucoma

## Interventions

- **BIOLOGICAL:** ANX007

## Key facts

- **NCT ID:** NCT03488550
- **Lead sponsor:** Annexon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-23
- **Primary completion:** 2018-08-03
- **Final completion:** 2018-08-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03488550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03488550, "Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03488550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*